Targeting the activation of Sirt2 expression, for instance, by generating a transgenic mouse overexpressing Sirt2 and crossing it with Sod1 knockout mice, could test whether this approach alleviates the premature aging and age-related neurodegenerative disease phenotypes observed in Sod1 knockout mice. Here, SOD1 is linked to neurodegenerative disease.